A 55-year-old with severe PAD underwent fem-pop bypass. Which antiplatelet/antithrombotic regimen is preferred to prevent limb events and MACE with ac...

Question

A 55-year-old with severe PAD underwent fem-pop bypass. Which antiplatelet/antithrombotic regimen is preferred to prevent limb events and MACE with acceptable bleeding risk?

Accepted Answer

Rivaroxaban 2.5 mg BID plus aspirin

Answer

Dual antiplatelet therapy indefinitely

Answer

Aspirin alone only

Answer

No antithrombotic therapy

Answer

Warfarin INR 2-3

us-abim MCQ (SBA): Post‑Revascularization Antithrombotics

A 55-year-old with severe PAD underwent fem-pop bypass. Which antiplatelet/antithrombotic regimen is preferred to prevent limb events and MACE with acceptable bleeding risk?